Lab Angelus, Inc. builds digital infrastructure and coordination platforms that connect community pathology laboratories with molecular reference laboratories for precision oncology. Its flagship product, LabDispatch, streamlines cancer specimen logistics and testing workflows to help patients receive timely molecular profiling and targeted treatments.
Subscribe to see Lab Angelus, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Lab Angelus, Inc. is a healthcare technology company headquartered in United States. Its most recent funding round raised $350,000 in August 2026. Xcout tracks 1 named person at Lab Angelus, Inc., including Samuel K Caughron (Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $350,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Lab Angelus, Inc.'s closest competitors — see the full list of competitors and alternatives →
Orchestra Health Technologies provides a platform combining proprietary software and care navigators to streamline the oncology diagnostic journey from biopsy to treatment decisions. The company serves cancer patients, oncologists, pathologists, and healthcare executives by coordinating pathology, molecular testing, and multi-disciplinary team workflows to accelerate precision medicine.
Tempus AI, Inc. is an American health technology company founded in 2015 in Chicago, Illinois. The company builds a practical platform to gather and analyze clinical and molecular data, empowering physicians to make data-driven patient care decisions.
Nexome Genomics provides cloud-based, integrated analytics solutions that process next-generation sequencing data for healthcare institutions. The company enables hospitals, medical centers, and physician offices to generate on-demand diagnostic and prognostic reports for precision medicine.
Valius Health, Inc. provides comprehensive cancer diagnostic and tumor profiling services for patients and oncologists. The company analyzes tumor DNA, RNA, and proteins to identify actionable therapeutic targets and treatment options.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Lab Angelus, Inc.? Suggest a correction · Work at Lab Angelus, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.